Advocacy intelligence hub — real-time data for patient organizations
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance2
Patient Assistance Programs1
WAINUA
AstraZeneca Pharmaceuticals LP
Tegsedi
(inotersen)Orphan drugIonis/AstraZeneca
Vyndaqel
(TAFAMIDIS MEGLUMINE)Orphan drugPfizer Laboratories Div Pfizer Inc
WAINUA
(EPLONTERSEN)Orphan drugAstraZeneca Pharmaceuticals LP
Onpattro
(PATISIRAN)Orphan drugAlnylam Pharmaceuticals, Inc.
AMVUTTRA
(VUTRISIRAN)Orphan drugAlnylam Pharmaceuticals, Inc.
John L. Berk, MD, D.D.S
Boston University
📍 CASTRO VALLEY, CA
John Vest, MD, BAS
Alnylam Pharmaceuticals
📍 COLORADO SPRINGS, CO
EMILIE GARRIDO PRADALIE
APHM DRIC
Mathew S Maurer, MD
Columbia University
Omar F Abou Ezzeddine, MD
Mayo Clinic
Erwan Donal
Rennes University Hospital